Subject index volume 34 (1995)

journal of Journal of Controlled Release 34 (1994) 283-284

ELSEVIER

controlled release

Subject Index Volume 34 (1995) Adriamycin, (34) 155 Alachlor, (34) 17 Alginate, (34) 17 Amphiphilic network, (34) 117 Analgesia, (34) 243 Apparent diffusion coefficient, (34) 65 Arthropathy, (34) 145 Available nutrients, (34) 25 AZT, (34) 43 Bioadhesion, (34) 251 Bioadhesive, (34) 251 Bioavailability, (34) 1, (34) 31, (34) 203 Biodegradable, (34) 87 Biodegradable hydrogel, (34) 155 Biodegradable microparticle, (34) 77 Biodegradable polymer, (34) 145 Biphasic hydrogel, (34) 185 Brain microvessel endothelial cell, (34) 233 Buprenorphine, (34) 243 Burst time, (34) 87 Capsule, (34) 87 Carvacrol, (34) 43 Casein, (34) 1 Chain-end scission, (34) 9 Characterization, (34) 193 Controlled drug delivery, (34) 167 Controlled drug release, (34) 155 Controlled release, (34) 1, (34) 17, (34) 77, (34) 117, (34) 185, (34) 263 Cross-linking, (34) 1 Cultured cell, (34) 233 Cytotoxicity, (34) 233 Degradation, (34) 9 Depolymerization, (34) 9 Dermal prodrug, (34) 223 Diffusion barrier, (34) 37 Diffusion in membranes, (34) 37 Doxorubicin, (34) 155 Drug targeting, (34) 155 Enhanced and dual-controlled skin permeation, (34) 129 Enhancer, (34) 43, (34) 129

Estradiol (E2), (34) 129 Ethanol, (34) 193 Ethylene/vinyl acetate (EVA) membrane, (34) 129 Experimental study, (34) 185 Fertilizer, (34) 25 Fibrin, (34) 65 Fibrinogen receptor antagonist, (34) 109 Food, (34) 31 Gradient system, (34) 263 Groundwater, (34) 17 Herbicide formulation, (34) 17 Hyaluronan, (34) 145 Hydrogel, (34) 167, (34) 185 Hydrolysis, (34) 9 Hydropbobic gel, (34) 117 Indomethacin, (34) 223 Insulin, (34) 117 Interferon, (34) 117 Intestinal absorption, (34) 109 In vitro - in vivo correlation, (34) 43 In vitro release, (34) 145 In vivo, (34) 223 Kaolin, (34) 17 Kinetics, (34) 25 Leaching, (34) 25 Levonorgestrel (LNG), (34) 129 Linalool, (34) 43 Linseed oil, (34) 17 Lipid composition, ( 34 ) 109 Liposome, (34) 53 L-menthol, (34) 43 Macromolecule, (34) 65 Macrophage, (34) 233 Mathematical model, (34) 185 Membrane, (34) 87 Membrane permeation-modulated transdermal delivery system, (34) 129 Methyl nicotinate, (34) 53

284

Subject Index / Journal of Controlled Release 34 (1994) 283-284

Methylprednisolone delivery, (34) 145 Micelle, (34) 117 Microbalance, (34) 251 Microemulsion, (34) 53 Microsphere, (34) 65 Microspheres, (34) 1 Miosis, (34) 243 Mucoadhesion, (34) 251 Mucoadhesive, (34) 243 N-(2-hydroxypropyl)methacrylamide, (34) 155 Naproxen, (34) 31 Nasal absorption, (34) 203 N-isopropylacrylamide, (34) 117 Nitroglycerin, (34) 193 Oral mucosa, (34) 243 Particle size, (34) 109 Permeation enhancer, (34) 193 Pharmacokinetics, (34) 109 Pharmacoscintigraphy, (34) 31 Phase separation, (34) 77 Phospholipid, (34) 53 Polycation, (34) 233 Poly(lactic-co-glycolic) acid (PLGA), (34) 87 Polylactide, (34) 9 Polymeric matrix, (34) 263 Polyoxyethylene glycol, (34) 223 Poly (D,L-lactide-co-glycolide), (34) 77 Poly(D,L-lactide), (34) 9 Potential barrier, (34) 37

Progesterone, (34) 117 Proliposome, (34) 203 Propranolol, (34) 203 Random scission, (34) 9 Reflectance spectrophotometry, (34) 53 Reflection coefficient, (34) 37 Release rate, (34) 167 Size exclusion in membranes, (34) 37 Skin permeation, (34) 53 Surfactant, (34) 117 Sustained activity, (34) 223 Sustained release, (34) 31, (34) 203 t-anethole, (34) 43 Theophylline, (34) 1 Thermoplastic, (34) 251 Thymol, (34) 43 Transdermal, (34) 43, (34) 193 Unzipping, (34) 9 Vegetable oil, (34) 17 Water-in-Oil microemulsion, (34) 109 X-ray fluorescence (XRF), (34) 167 Zeolite, (34) 25 Zero-order, (34) 263 Zero-order release, (34) 185